BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 32466780)

  • 1. Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.
    Tohyama T; Sakamoto K; Tamura K; Nakamura T; Watanabe J; Wakisaka H; Takada Y
    World J Surg Oncol; 2020 May; 18(1):109. PubMed ID: 32466780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Recurrent HCC After Liver Transplantation.
    Sarici B; Isik B; Yilmaz S
    J Gastrointest Cancer; 2020 Dec; 51(4):1197-1199. PubMed ID: 32839944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma with pharyngeal metastasis: report of a case.
    Nagao Y; Cho A; Yamamoto H; Kainuma O; Gunji H; Miyazaki A; Ozaki D
    Surg Today; 2008; 38(11):1060-2. PubMed ID: 18958569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation.
    Na GH; Hong TH; You YK; Kim DG
    World J Gastroenterol; 2016 Jul; 22(25):5790-9. PubMed ID: 27433092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma].
    Wang J; He BJ; Jiang ZB; Zhang YQ; Shan H; Xiao R; Zhang JS; Luo L; Kuang SC; Chen GH; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):691-6. PubMed ID: 20021867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria.
    Cho Y; Lee JH; Lee DH; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS
    Oncotarget; 2017 Jul; 8(29):47555-47564. PubMed ID: 28548930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of advanced hepatocellular carcinoma with lung, brain and lymph node metastases recurred 8 years after hepatectomy successfully treated by operation, radiation and systemic chemotherapy using S-1/CDDP].
    Kagawa K; Kawakami Y; Honda Y; Nakahara T; Tanaka M; Naeshiro N; Miyaki D; Nagaoki Y; Kawaoka T; Takaki S; Hiramatsu A; Waki K; Hyogo H; Aikata H; Takahashi S; Arihiro K; Sanetou H; Chayama K
    Nihon Shokakibyo Gakkai Zasshi; 2012 Aug; 109(8):1401-8. PubMed ID: 22863965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local therapy improvement of outcome in a patient with recurrent hepatocellular carcinoma after living donor liver transplantation: a case report.
    Shimokawa M; Itoh S; Ikegami T; Takeishi K; Harimoto N; Yamashita YI; Yoshizumi T; Kawanaka H; Shirabe K; Maehara Y
    Anticancer Res; 2015 Jun; 35(6):3525-9. PubMed ID: 26026120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience.
    Victor DW; Monsour HP; Boktour M; Lunsford K; Balogh J; Graviss EA; Nguyen DT; McFadden R; Divatia MK; Heyne K; Ankoma-Sey V; Egwim C; Galati J; Duchini A; Saharia A; Mobley C; Gaber AO; Ghobrial RM
    Transplantation; 2020 Jan; 104(1):113-121. PubMed ID: 31233480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of living donor liver transplantation after locoregional treatment for hepatocellular carcinoma: an experience from a single institute.
    Inomata K; Yagi H; Hibi T; Shinoda M; Matsubara K; Abe Y; Kitago M; Obara H; Itano O; Kawachi S; Tanabe M; Wakabayashi G; Shimazu M; Kitagawa Y
    Surg Today; 2021 Mar; 51(3):350-357. PubMed ID: 32767130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
    Kim YR; Park S; Han S; Ahn JH; Kim S; Sinn DH; Jeong WK; Ko JS; Gwak MS; Kim GS
    Sci Rep; 2018 May; 8(1):7157. PubMed ID: 29740069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living-donor liver transplantation for hepatocellular carcinoma.
    Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
    Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living Donor Versus Deceased Donor Liver Transplantation for HCC.
    Doğan SM; Kutlutürk K
    J Gastrointest Cancer; 2020 Dec; 51(4):1104-1106. PubMed ID: 32833221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW; Yi NJ; Suh KS
    Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma with metastasis to the pharynx: report of a case.
    Oida Y; Ishii M; Dowaki S; Tobita K; Ohtani Y; Imaizumi T; Abe Y; Yamazaki H; Nakamura M; Makuuchi H
    Tokai J Exp Clin Med; 2005 Apr; 30(1):31-4. PubMed ID: 15952296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha.
    Nakamura M; Nagano H; Wada H; Noda T; Ota H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M
    J Gastroenterol; 2006 Nov; 41(11):1120-5. PubMed ID: 17160524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.